BIO-key International (NASDAQ:BKYI) Stock Passes Above 50-Day Moving Average – Time to Sell?

BIO-key International Inc. (NASDAQ:BKYIGet Free Report) shares crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.76 and traded as high as $0.80. BIO-key International shares last traded at $0.77, with a volume of 74,785 shares changing hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of BIO-key International in a research report on Friday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, BIO-key International currently has a consensus rating of “Sell”.

Get Our Latest Stock Report on BKYI

BIO-key International Stock Up 1.6%

The company’s 50-day moving average is $0.76 and its two-hundred day moving average is $0.78. The company has a market capitalization of $5.29 million, a P/E ratio of -0.60 and a beta of 0.41.

BIO-key International (NASDAQ:BKYIGet Free Report) last posted its quarterly earnings data on Wednesday, August 13th. The technology company reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.05). The company had revenue of $1.70 million during the quarter, compared to the consensus estimate of $1.70 million. BIO-key International had a negative return on equity of 92.10% and a negative net margin of 60.92%.

BIO-key International Company Profile

(Get Free Report)

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.

Read More

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.